News
Groupon to Participate in the Credit Suisse 26th Annual Technology Conference
Groupon, Inc. (NASDAQ: GRPN) announced that Kedar Deshpande, Chief Executive Officer, and Damien Schmitz, Chief Financial Officer, will participate in the Credit Suisse 26th Annual Technology
Navidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
Novolipetsk Steel: Update regarding the coupon payment for the Eurobonds due 2024
Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that its partner
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
Charles River Laboratories International, Inc. (NYSE: CRL) recently opened the first Charles River Accelerator and Development Lab (CRADL®) location in Chicago, expanding contract vivarium space
Home-Price Growth Is Cooling Fastest in Pandemic Boomtowns Like Austin and Boise
(NASDAQ: RDFN) — Home-price growth has slowed fastest in pandemic boomtowns including Austin, Phoenix and Boise as high mortgage rates and an uncertain economy deter would-be buyers. This is
Form 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group plc
Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Exscientia plc (Nasdaq: EXAI) today announced clinical trial application (CTA) approval of IGNITE-AI, enabling site activation in its first European country. IGNITE-AI is a Phase 1/2 trial studying
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Imperalis Holding Corp. Reports Third Quarter 2022 Financial Results
Imperalis Holding Corporation (“Imperalis” OTC: IMHC), to be renamed TurnOnGreen, Inc., an emerging electric vehicle (“EV”) electrification infrastructure solutions and premium custom power
BitNile Holdings Contemplates Exchange Offer to Acquire Shares of Its Common Stock
BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or the “Company”), today announced that the Company is considering undertaking an exchange offer (the “Offer”)
PMHH Becomes the Owner of 93.11 Percent of the Shares in Swedish Match, and Intends to Initiate Compulsory Redemption and Request Delisting
Regulatory News:
This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand, or South Africa or in any other jurisdiction where such offer
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD)
EQS-News: Francotyp-Postalia Holding AG: Acquisition of treasury shares – 4th interim report
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
EQS-News: Corestate Capital Holding S.A.: Creditors' meeting approves bond restructuring plan and lays foundation for company's going concern
EQS-Adhoc: Corestate Capital Holding S.A.: Creditors' meetings approve modified restructuring concept
Aroundtown SA: Release of a capital market information
EQS-News: beaconsmind AG strengthens market position in the Middle East: beaconsmind's LBM solution to have a significant contribution towards Saudi Arabia's “Vision 2030”
EQS-News: Mynaric delivers HAWK terminals to new commercial U.S.-based energy customer